CommercialBilling CodesMedium impact
07.07.03o, Photodynamic Therapy (PDT) Using Levulan® Kerastick® or Ameluz® (Aminolevulinic Acid HCl [ALA])
Independence Blue Cross·PA · Dermatology, Oncology, Pharmacy·Pharmacy
Effective date
Jan 1, 2026
We identified it
Jun 19, 2026
Summary
Independence Blue Cross removed HCPCS code J7309 from the Photodynamic Therapy (PDT) policy effective January 1, 2026, as part of a routine HCPCS code update. The policy reissue on March 4, 2026 confirms the company's continued coverage positions for PDT using Levulan Kerastick or Ameluz for specified dermatological indications. Billing teams must ensure J7309 is no longer used for claims submission.
Action Required
By January 1, 2026: Billing team must update billing software to remove HCPCS code J7309 from all PDT claim submissions. Verify that J7308 and J7345 remain active for aminolevulinic acid HCl topical administration. Remove J7309 from any standing billing rules, templates, or superbill configurations. Flag any historical claims using J7309 for potential reworking if they were submitted after the effective date. Notify providers that J7309 is terminated and direct them to use only J7308 or J7345 depending on the formulation and dosage. Failure to remove J7309 will result in claim denials and billing errors.